Product Information

TOPIRAMATE ER 200 MG CAPSULE is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $23.2096 per EA under NDC 00480235901. Its NADAC has been published 158 times since Jun 21, 2023.

TOPIRAMATE ER 200 MG CAPSULE

Topiramate
$23.2096per EA

Strength

200 mg/1

NDC

00480235901

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

TOPIRAMATE

Approval Type

Generic (ANDA)

FDA Application

ANDA206210

On Market Since

3/31/2023

Pharmacological Classes

Cytochrome P450 2C19 Inhibitors
Cytochrome P450 3A4 Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for TOPIRAMATE ER 200 MG CAPSULE has been published 158 times since Jun 21, 2023, and over the history we have for it it has declined 31.4%. The table below summarizes its recorded NADAC range and movement.

Current price$23.2096 per EA
All-time high$34.7626 (Jan 10, 2024)
All-time low$18.7572 (Jul 17, 2024)
52-week high$25.8176
52-week low$22.2272
Median price$25.6532
Average price$26.6433
Largest weekly change+22.6% (Nov 22, 2023)
Weeks tracked158
Tracking sinceJun 21, 2023

Price History

1W

0.0%

1M

+2.2%

3M

+4.4%

6M

-8.9%

1Y

-8.3%

3Y

-31.4%

5Y

N/A

All

-31.4%

Generic Alternatives

The matcher finds 12 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 100% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TOPIRAMATE ER 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TOPIRAMATE ER 200 MG CAPSULE, manufactured by Teva Pharmaceuticals USA Inc., is $23.2096 per EA (NDC 00480235901), effective Jun 24, 2026.

How has the price of TOPIRAMATE ER 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has declined 31.4%. It has been tracked across 158 weekly CMS publications since Jun 21, 2023.

What are the highest and lowest recorded NADAC prices for TOPIRAMATE ER 200 MG CAPSULE?

Since Jun 21, 2023, the NADAC for TOPIRAMATE ER 200 MG CAPSULE has ranged from a low of $18.7572 (Jul 17, 2024) to a high of $34.7626 (Jan 10, 2024), with a median of $25.6532 per EA.

Are there cheaper alternatives to TOPIRAMATE ER 200 MG CAPSULE?

Yes. 12 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TOPIRAMATE 200 MG TABLET, is $0.0880 per EA — about 100% below TOPIRAMATE ER 200 MG CAPSULE.

Who manufactures TOPIRAMATE ER 200 MG CAPSULE?

TOPIRAMATE ER 200 MG CAPSULE (NDC 00480235901) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.